Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer

L. T. Vahdat, C. Balmaceda, K. Papadopoulos, D. Frederick, D. Donovan, E. Sharpe, E. Kaufman, D. Savage, A. Tiersten, G. Nichols, J. Haythe, A. Troxel, K. Antman, C. S. Hesdorffer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences